(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC39A6 mRNA] CTD PMID:31150632 (S)-nicotine increases expression ISO RGD:1312236 6480464 Nicotine results in increased expression of SLC39A6 mRNA CTD PMID:16949557 1,1-dichloroethene increases expression ISO RGD:1312237 6480464 vinylidene chloride results in increased expression of SLC39A6 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1312237 6480464 ethylene dichloride results in decreased expression of SLC39A6 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SLC39A6 mRNA CTD PMID:25380136 17alpha-ethynylestradiol multiple interactions ISO RGD:1312237 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A6 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1312236 6480464 Estradiol results in increased expression of SLC39A6 mRNA CTD PMID:16514628 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312237 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A6 mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC39A6 mRNA CTD PMID:17942748 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC39A6 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312237 6480464 Tetrachlorodibenzodioxin affects the expression of SLC39A6 mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC39A6 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SLC39A6 mRNA CTD PMID:25380136 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC39A6 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC39A6 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1312236 6480464 Acrylamide results in increased expression of SLC39A6 mRNA CTD PMID:32763439 afimoxifene decreases expression ISO RGD:1312236 6480464 afimoxifene results in decreased expression of SLC39A6 mRNA CTD PMID:16514628 aflatoxin B1 affects expression ISO RGD:1312236 6480464 Aflatoxin B1 affects the expression of SLC39A6 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1312236 6480464 Aflatoxin B1 results in increased methylation of SLC39A6 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1312236 6480464 Aflatoxin B1 results in increased expression of SLC39A6 mRNA CTD PMID:27153756 Aroclor 1254 decreases expression ISO RGD:1312237 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC39A6 mRNA CTD PMID:23650126 arsenite(3-) increases methylation ISO RGD:1312236 6480464 arsenite results in increased methylation of SLC39A6 promoter CTD PMID:23974009 benzo[a]pyrene increases expression ISO RGD:1312237 6480464 Benzo(a)pyrene results in increased expression of SLC39A6 mRNA CTD PMID:22228805 , PMID:23735875 benzo[a]pyrene increases expression ISO RGD:1312236 6480464 Benzo(a)pyrene results in increased expression of SLC39A6 mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1312236 6480464 7 more ... CTD PMID:26238291 bisphenol A increases expression ISO RGD:1312236 6480464 bisphenol A results in increased expression of SLC39A6 mRNA CTD PMID:26363213 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC39A6 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC39A6 mRNA CTD PMID:25181051 buta-1,3-diene increases expression ISO RGD:1312237 6480464 1, 3-butadiene results in increased expression of SLC39A6 mRNA CTD PMID:21147608 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC39A6 mRNA CTD PMID:33453195 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of SLC39A6 mRNA CTD PMID:29548726 calcitriol decreases expression ISO RGD:1312236 6480464 Calcitriol results in decreased expression of SLC39A6 mRNA CTD PMID:20089671 cannabidiol increases expression ISO RGD:1312237 6480464 Cannabidiol results in increased expression of SLC39A6 mRNA CTD PMID:31052254 CGP 52608 multiple interactions ISO RGD:1312236 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC39A6 gene] CTD PMID:28238834 copper(II) sulfate increases expression ISO RGD:1312236 6480464 Copper Sulfate results in increased expression of SLC39A6 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC39A6 mRNA CTD PMID:27523638 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of SLC39A6 mRNA CTD PMID:27281708 cyclosporin A increases expression ISO RGD:1312236 6480464 Cyclosporine results in increased expression of SLC39A6 mRNA CTD PMID:20106945 dextran sulfate multiple interactions ISO RGD:1312237 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA CTD PMID:29950665 dibutyl phthalate increases expression ISO RGD:1312237 6480464 Dibutyl Phthalate results in increased expression of SLC39A6 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1312236 6480464 dicrotophos results in decreased expression of SLC39A6 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1312236 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1312236 6480464 Doxorubicin results in decreased expression of SLC39A6 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:1312236 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLC39A6 protein CTD PMID:23301498 ethanol affects splicing ISO RGD:1312237 6480464 Ethanol affects the splicing of SLC39A6 mRNA CTD PMID:30319688 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC39A6 mRNA CTD PMID:24793618 fulvestrant decreases expression ISO RGD:1312236 6480464 fulvestrant results in decreased expression of SLC39A6 mRNA CTD PMID:16514628 geldanamycin increases expression ISO RGD:1312236 6480464 geldanamycin results in increased expression of SLC39A6 mRNA CTD PMID:26705709 hypochlorous acid increases expression ISO RGD:1312237 6480464 Hypochlorous Acid results in increased expression of SLC39A6 mRNA CTD PMID:19376150 lipopolysaccharide decreases expression ISO RGD:1312237 6480464 Lipopolysaccharides results in decreased expression of SLC39A6 mRNA, Lipopolysaccharides results in decreased expression of SLC39A6 protein CTD PMID:16892068 , PMID:17126599 lipopolysaccharide multiple interactions ISO RGD:1312237 6480464 SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc], TICAM1 protein affects the reaction [Lipopolysaccharides results in decreased expression of SLC39A6 protein] CTD PMID:16892068 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of SLC39A6 mRNA CTD PMID:28935588 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:1312236 6480464 N more ... CTD PMID:19887557 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of SLC39A6 mRNA CTD PMID:25380136 nicotine increases expression ISO RGD:1312236 6480464 Nicotine results in increased expression of SLC39A6 mRNA CTD PMID:16949557 ochratoxin A decreases expression ISO RGD:1312236 6480464 ochratoxin A results in decreased expression of SLC39A6 mRNA CTD PMID:30559759 panobinostat decreases expression ISO RGD:1312236 6480464 panobinostat results in decreased expression of SLC39A6 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1312237 6480464 Acetaminophen affects the expression of SLC39A6 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1312236 6480464 Acetaminophen results in increased expression of SLC39A6 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1312237 6480464 Acetaminophen results in increased expression of SLC39A6 mRNA CTD PMID:19420014 pirinixic acid multiple interactions ISO RGD:1312237 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC39A6 mRNA CTD PMID:19710929 propiconazole increases expression ISO RGD:1312237 6480464 propiconazole results in increased expression of SLC39A6 mRNA CTD PMID:21278054 raloxifene decreases expression ISO RGD:1312236 6480464 Raloxifene Hydrochloride results in decreased expression of SLC39A6 mRNA CTD PMID:16514628 SB 431542 multiple interactions ISO RGD:1312236 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:1312236 6480464 Asbestos, Serpentine results in increased expression of SLC39A6 mRNA CTD PMID:21148743 Soman increases expression EXP 6480464 Soman results in increased expression of SLC39A6 mRNA CTD PMID:19281266 tetrachloromethane increases expression ISO RGD:1312237 6480464 Carbon Tetrachloride results in increased expression of SLC39A6 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC39A6 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC39A6 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC39A6 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:1312237 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA CTD PMID:29950665 torcetrapib increases expression ISO RGD:1312236 6480464 torcetrapib results in increased expression of SLC39A6 mRNA CTD PMID:23228038 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC39A6 mRNA CTD PMID:33387578 trichostatin A decreases response to substance ISO RGD:1312236 6480464 SLC39A6 mutant form results in decreased susceptibility to trichostatin A CTD PMID:19887557 trichostatin A decreases expression ISO RGD:1312236 6480464 trichostatin A results in decreased expression of SLC39A6 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A increases expression ISO RGD:1312236 6480464 trichostatin A results in increased expression of SLC39A6 mRNA, trichostatin A results in increased expression of SLC39A6 protein CTD PMID:19887557 trichostatin A multiple interactions ISO RGD:1312236 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:19887557 , PMID:27188386 trimellitic anhydride increases expression ISO RGD:1312237 6480464 trimellitic anhydride results in increased expression of SLC39A6 mRNA CTD PMID:19042947 valproic acid increases expression ISO RGD:1312236 6480464 Valproic Acid results in increased expression of SLC39A6 mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1312236 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1312236 6480464 Valproic Acid results in decreased expression of SLC39A6 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1312236 6480464 Valproic Acid affects the expression of SLC39A6 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:1312237 6480464 Vancomycin results in decreased expression of SLC39A6 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC39A6 mRNA CTD PMID:22570695 vorinostat decreases response to substance ISO RGD:1312236 6480464 SLC39A6 mutant form results in decreased susceptibility to vorinostat CTD PMID:19887557 zearalenone increases expression ISO RGD:1312236 6480464 Zearalenone results in increased expression of SLC39A6 mRNA CTD PMID:28965971 zinc atom increases expression ISO RGD:1312237 6480464 Zinc deficiency results in increased expression of SLC39A6 protein CTD PMID:25088245 zinc atom increases uptake ISO RGD:1312236 6480464 SLC39A6 protein results in increased uptake of Zinc CTD PMID:12839489 zinc atom affects uptake ISO RGD:1312236 6480464 SLC39A6 protein affects the uptake of Zinc CTD PMID:18272141 zinc atom multiple interactions ISO RGD:1312236 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19887557 zinc atom affects expression EXP 6480464 Zinc affects the expression of SLC39A6 mRNA CTD PMID:15867272 zinc atom decreases expression ISO RGD:1312237 6480464 Zinc results in decreased expression of SLC39A6 mRNA CTD PMID:17085522 zinc atom multiple interactions ISO RGD:1312237 6480464 SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc] CTD PMID:16892068 zinc atom increases transport ISO RGD:1312236 6480464 SLC39A6 protein results in increased transport of Zinc CTD PMID:18326752 zinc(0) increases expression ISO RGD:1312237 6480464 Zinc deficiency results in increased expression of SLC39A6 protein CTD PMID:25088245 zinc(0) increases transport ISO RGD:1312236 6480464 SLC39A6 protein results in increased transport of Zinc CTD PMID:18326752 zinc(0) multiple interactions ISO RGD:1312237 6480464 SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc] CTD PMID:16892068 zinc(0) decreases expression ISO RGD:1312237 6480464 Zinc results in decreased expression of SLC39A6 mRNA CTD PMID:17085522 zinc(0) affects expression EXP 6480464 Zinc affects the expression of SLC39A6 mRNA CTD PMID:15867272 zinc(0) multiple interactions ISO RGD:1312236 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19887557 zinc(0) affects uptake ISO RGD:1312236 6480464 SLC39A6 protein affects the uptake of Zinc CTD PMID:18272141 zinc(0) increases uptake ISO RGD:1312236 6480464 SLC39A6 protein results in increased uptake of Zinc CTD PMID:12839489
